The aim of APIS Assay Technologies is to help to realise the clinical and commercial potential of genomic medicine in diagnostic tests and personalisation of treatment.
A collaboration between Greater Manchester and the National Institute for Health and Care Excellence (NICE) that seeks to improve the health of the local population has been expanded for a further three years.